Upload independent
View 1
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys
Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
Preparation and Evaluation of Sustained-Release Doxazosin Mesylate Pellets
Safety, tolerability and efficacy of levodopa–carbidopa treatment for cocaine dependence: Two double-blind, randomized, clinical trials
Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI -- a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
Synthesis and Investigation of Colon specific Polymeric prodrug of Ibuprofen with Cyclodextrin
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
A mitochondrial-targeted prodrug for NIR imaging guided and
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
Polyaspartamide-Doxorubicin Conjugate as Potential Prodrug for Anticancer Therapy
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model
Structure and conformational analysis of the anti-HIV AZT 5'-aminocarbonylphosphonate prodrug using DFT methods
Acute oral toxicity and biodistribution study of zinc-aluminium-levodopa nanocomposite
A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy
A novel cytarabine crystalline lipid prodrug: Hexadecyloxypropyl cytarabine 3′,5′-cyclic monophosphate for proliferative vitreoretinopathy
Levodopa effects on [11C]raclopride binding in the resting human brain [v1; referees: 3 approved]
Responsiveness to levodopa in epsilon-sarcoglycan deletions
Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate
Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels
Treatment of Human Immunodeficiency Virus 1‐Infected Infants and Children with the Protease Inhibitor Nelfinavir Mesylate
The effect of Parkinson’s disease and levodopa on adaptation of anticipatory postural adjustments
Specificity of a Prodrug-Activating Enzyme hVACVase: The Leaving Group Effect
IMP - GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism
Pharmacokinetic–pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism
![Levodopa effects on [11C]raclopride binding in the resting human brain [v1; referees: 3 approved]](https://img.pdfslide.net/doc/110x75/634f1846eb0b18f1440ab01e/levodopa-effects-on-11craclopride-binding-in-the-resting-human-brain-v1-referees.jpg)
